Genus plc (LON:GNS - Get Free Report) passed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of GBX 2,169.65 ($29.25) and traded as high as GBX 2,550 ($34.38). Genus shares last traded at GBX 2,530 ($34.11), with a volume of 139,621 shares trading hands.
Wall Street Analyst Weigh In
A number of analysts recently issued reports on the company. Shore Capital reiterated a "buy" rating and issued a GBX 2,900 price target on shares of Genus in a report on Thursday, September 4th. Deutsche Bank Aktiengesellschaft boosted their price target on Genus from GBX 2,550 to GBX 2,900 and gave the company a "buy" rating in a report on Monday, September 15th. Two equities research analysts have rated the stock with a Buy rating, According to MarketBeat, Genus currently has an average rating of "Buy" and a consensus target price of GBX 2,900.
Read Our Latest Stock Analysis on Genus
Genus Stock Performance
The business has a fifty day simple moving average of GBX 2,543.20 and a two-hundred day simple moving average of GBX 2,169.65. The company has a debt-to-equity ratio of 53.12, a current ratio of 1.80 and a quick ratio of 1.08. The company has a market cap of £1.66 billion, a PE ratio of -40,806.45, a price-to-earnings-growth ratio of 2.87 and a beta of 0.37.
Genus (LON:GNS - Get Free Report) last posted its earnings results on Thursday, September 4th. The company reported GBX 81.80 earnings per share for the quarter. Genus had a return on equity of 1.41% and a net margin of 1.18%. Research analysts anticipate that Genus plc will post 70.9644323 earnings per share for the current year.
Insider Activity at Genus
In other news, insider Jorgen Kokke sold 3,450 shares of the stock in a transaction on Thursday, September 25th. The stock was sold at an average price of GBX 2,332, for a total transaction of £80,454. Corporate insiders own 0.59% of the company's stock.
Genus Company Profile
(
Get Free Report)
Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Genus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genus wasn't on the list.
While Genus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
